Why Researchers Are Choosing INano™ S Microfluidic Equipment for Controlled Nanoformulation
The rapid advancement of genetic medicines—particularly mRNA vaccines, siRNA therapeutics, and next-generation nucleic acid delivery systems—has exposed a persistent and critical manufacturing bottleneck: the reproducible and scalable formulation of lipid nanoparticles (LNPs). While conventional mixing approaches may be adequate for early-stage laboratory exploration, they struggle...
0 发布评论计数 0 分享 171 查看 0 評論